These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7539507)

  • 61. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
    Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
    Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.
    Carr JM; Cheney KM; Coolen C; Davis A; Shaw D; Ferguson W; Chang G; Higgins G; Burrell C; Li P
    J Clin Microbiol; 2007 Apr; 45(4):1288-97. PubMed ID: 17314225
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phenotypic analysis of peripheral blood gammadelta T lymphocytes and their targeting by human immunodeficiency virus type 1 in vivo.
    Imlach S; Leen C; Bell JE; Simmonds P
    Virology; 2003 Jan; 305(2):415-27. PubMed ID: 12573587
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules.
    Cosma A; Blanc D; Braun J; Quillent C; Barassi C; Moog C; Klasen S; Spire B; Scarlatti G; Pesenti E; Siccardi AG; Beretta A
    AIDS; 1999 Oct; 13(15):2033-42. PubMed ID: 10546855
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Full expression of transfected nonproducer interfering HIV-1 proviral DNA abrogates susceptibility of human He-La CD4+ cells to HIV.
    Federico M; Nappi F; Bona R; D'Aloja P; Verani P; Rossi GB
    Virology; 1995 Jan; 206(1):76-84. PubMed ID: 7831838
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group.
    Livingstone WJ; Moore M; Innes D; Bell JE; Simmonds P
    Lancet; 1996 Sep; 348(9028):649-54. PubMed ID: 8782755
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells.
    Fantini J; Yahi N; Chermann JC
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9297-301. PubMed ID: 1718004
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex.
    Park EJ; Gorny MK; Zolla-Pazner S; Quinnan GV
    J Virol; 2000 May; 74(9):4183-91. PubMed ID: 10756031
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Compartmentalization of human immunodeficiency virus type 1 between blood monocytes and CD4+ T cells during infection.
    Fulcher JA; Hwangbo Y; Zioni R; Nickle D; Lin X; Heath L; Mullins JI; Corey L; Zhu T
    J Virol; 2004 Aug; 78(15):7883-93. PubMed ID: 15254161
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stable human immunodeficiency virus type 1 (HIV-1) resistance in transformed CD4+ monocytic cells treated with multitargeting HIV-1 antisense sequences incorporated into U1 snRNA.
    Liu D; Donegan J; Nuovo G; Mitra D; Laurence J
    J Virol; 1997 May; 71(5):4079-85. PubMed ID: 9094686
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion.
    Schnittman SM; Denning SM; Greenhouse JJ; Justement JS; Baseler M; Kurtzberg J; Haynes BF; Fauci AS
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7727-31. PubMed ID: 2217206
    [TBL] [Abstract][Full Text] [Related]  

  • 73. HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes.
    Liegler TJ; Stites DP
    J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):340-8. PubMed ID: 7907660
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vaccination with feline immunodeficiency virus induces CD4 epitope masking by soluble factors.
    Leutenegger CM; Holznagel E; Hofmann-Lehmann R; Aubert A; Tompkins MB; Lutz H
    Vet Immunol Immunopathol; 2000 Mar; 73(3-4):343-52. PubMed ID: 10713346
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of CD4 on human peripheral blood neutrophils.
    Biswas P; Mantelli B; Sica A; Malnati M; Panzeri C; Saccani A; Hasson H; Vecchi A; Saniabadi A; Lusso P; Lazzarin A; Beretta A
    Blood; 2003 Jun; 101(11):4452-6. PubMed ID: 12531788
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial.
    Chege D; Kovacs C; la Porte C; Ostrowski M; Raboud J; Su D; Kandel G; Brunetta J; Kim CJ; Sheth PM; Kaul R; Loutfy MR
    AIDS; 2012 Jan; 26(2):167-74. PubMed ID: 22089379
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.
    Lusso P; Cocchi F; Balotta C; Markham PD; Louie A; Farci P; Pal R; Gallo RC; Reitz MS
    J Virol; 1995 Jun; 69(6):3712-20. PubMed ID: 7745720
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals.
    Schnittman SM; Lane HC; Greenhouse J; Justement JS; Baseler M; Fauci AS
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6058-62. PubMed ID: 2385584
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4.
    Schnittman SM; Psallidopoulos MC; Lane HC; Thompson L; Baseler M; Massari F; Fox CH; Salzman NP; Fauci AS
    Science; 1989 Jul; 245(4915):305-8. PubMed ID: 2665081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.